Sleuthing needed to solve cases of adult-onset diplopia

Article

The great fictional detective Sherlock Holmes believed that once you have eliminated the impossible, whatever remains-however unlikely it may be-must be the answer.

New York-The great fictional detective Sherlock Holmes believed that once you have eliminated the impossible, whatever remains-however unlikely it may be-must be the answer.

According to Dr. Thimons, who is medical director, Ophthalmic Consultants of Connecticut, Fairfield, CT, adult-onset diplopia is one of the more common areas of clinical practice as far as neuro-ophthalmic patients go. Both the presentation and the diagnosis can be complex, or conversely fairly simple, he said, but even the most challenging cases should not be beyond the skill of a well-trained clinical practitioner to diagnose.

The evaluation of patients with diplopia must include a comprehensive, system-wide analysis of function. Start with a thorough history, including personal behavior, pharmaceutical use, recreational drug use, changes in lifestyles, and changes in behavior.

"Listen to your patients, and they will tell you their disease," Dr. Thimons said.

The eventual diagnosis can often come from good observation on the part of the clinician. By recognizing effects (or lack thereof) on a patient's cognitive and motor skills, an optometrist may decide to pursue a more aggressive examination. Be a good observer of the person who's in the chair, Dr. Thimons said, as opposed to examining just the small subset of the ocular findings.

"In patients with possible masquerading syndromes such the neuron-degenerative diseases, Alzheimer's or Parkinson's, or the atypical extraocular muscle function problem, patients with possible systemic concerns such as multiple sclerosis, myasthenia gravis, or thyroid eye disease. Everything is potentially important: every element of history and every nuance of the physical examination need to be viewed from a global perspective," Dr. Thimons said.

Recent Videos
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
Sherrol Reynolds, OD, FAAO, said that multimodel imaging has been a game changer in assessing the choroidal function and structural changes in various disease conditions.
Susan Gromacki, OD, FAAO, FSLS, provides key takeaways from this year's American Academy of Optometry symposium genetics and the cornea.
Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.
Ian Ben Gaddie, OD, FAAO, outlines key findings from a recent study evaluating lotilaner in patients with Demodex blepharitis and meibomian gland dysfunction.
© 2024 MJH Life Sciences

All rights reserved.